A Small Molecule Antagonist of CX3CR1 (KAND567) Inhibited the Tumor Growth-Promoting Effect of Monocytes in Chronic Lymphocytic Leukemia (CLL). The gene discussed is CX3CR1; the disease is B-cell chronic lymphocytic leukemia.